What is Planatome?
Founded in 2017 and headquartered in Phoenix, Arizona, Planatome operates under the Entrepix Medical umbrella, dedicated to enhancing existing medical tools and technology. The company's core focus is on developing advanced scalpel blade technology designed to elevate performance standards, ultimately benefiting healthcare professionals and patients alike. Planatome's commitment to precision engineering positions it as a key player in the medical device sector, aiming to refine surgical outcomes through technological advancement.
How much funding has Planatome raised?
Planatome has raised a total of $6M across 2 funding rounds:
Series A
$5M
Debt
$1M
Series A (2023): $5M, investors not publicly disclosed
Debt (2023): $1M, investors not publicly disclosed
What's next for Planatome?
With this substantial enterprise-level backing, Planatome is poised for accelerated growth and market expansion. The strategic investment is expected to fuel further research and development into its scalpel blade technology, potentially leading to new product iterations and broader applications within the medical field. This financing round signals a critical phase for the company, enabling it to scale operations, enhance its manufacturing capabilities, and solidify its market presence. The focus will likely be on translating technological innovation into tangible commercial success and further establishing its value proposition in the competitive healthcare landscape.
See full Planatome company page
